Conditions: Soft Tissue Sarcoma
Keywords: Soft Tissue Sarcoma CC-4047 Pomalidomide
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 7
Healthy volunteers: no

Brief summary:
The purpose of the study is to determine the safety and efficacy of single agent CC-4047 (pomalidomide) in patients with advanced soft tissue sarcomas who have relapsed or are refractory to prior anticancer therapy.

Detailed description:

Arms:
arm 1: 7 mg pomalidomide taken orally once daily (QD) on days 1 through 21 of each 28-day cycle

Interventions: intervention 1: Pomalidomide
Intervention descriptions: intervention 1: None

Protocol document: